← brief for 2026-10-15 · Slowing decline

GLP-1 Receptor Agonists and Lipoprotein (a): Insights, Gaps and Clinical Implications in Cardiovascular Diseases.

Paper No results yet Peer reviewed

Key takeaways

This review looks at how GLP-1 drugs affect a heart risk marker called Lp(a). It discusses the link between these drugs and heart health. It does not report new trial results.

Who did this work

Mikhael FG · Ayoub C · Teperikidis E · Biondi-Zoccai G · Booz GW · Zouein FA · Makarem NN

Source

Paper · PubMed, the drug frontier · 2026 Oct 15
https://pubmed.ncbi.nlm.nih.gov/42878985/